FOR PHARMA

Improved Tolerability Stronger Outcomes

Our technologies support tolerability and adherence—without complicating delivery.

Fewer side-effect costs

Better treatment adherence

Less pressure on clinics

FOR PHARMA

Improved Tolerability Stronger Outcomes

Our technologies support tolerability and adherence—without complicating delivery.

Fewer side-effect costs

Better treatment adherence

Less pressure on clinics

FOR PHARMA

Improved Tolerability Stronger Outcomes

Our technologies support tolerability and adherence—without complicating delivery.

Fewer side-effect costs

Better treatment adherence

Less pressure on clinics

Improved Dose Completion

Lilac is built to reduce the risk of drug-induced peripheral neuropathy (DIPN) - a leading cause of dose reductions and treatment dropouts.

Improved Dose Completion

Lilac is built to reduce the risk of drug-induced peripheral neuropathy (DIPN) - a leading cause of dose reductions and treatment dropouts.

Improved Dose Completion

Lilac is built to reduce the risk of drug-induced peripheral neuropathy (DIPN) - a leading cause of dose reductions and treatment dropouts.

Enhanced Patient Experience

Lilac helps patients feel more like themselves. Managing nerve pain from cancer treatment improves quality of life, daily function and overall patient experience.

68% of cancer patients get some form of life-changing peripheral neuropathy

Enhanced Patient Experience

Lilac helps patients feel more like themselves. Managing nerve pain from cancer treatment improves quality of life, daily function and overall patient experience.

68% of cancer patients get some form of life-changing peripheral neuropathy

Enhanced Patient Experience

Lilac helps patients feel more like themselves. Managing nerve pain from cancer treatment improves quality of life, daily function and overall patient experience.

68% of cancer patients get some form of life-changing peripheral neuropathy

Flexible collaboration, real-world impact.

We work with clinical, commercial, and medical affairs teams to test and deploy technologies, designed to improve tolerability and simplify administration. Whether you're exploring real-world evidence, enhancing trial experience, or planning for market differentiation, we adapt to your goals.

Integrates into clinical protocols

Supports RWE generation

Aligns with strategic portfolio goals

Flexible collaboration, real-world impact.

We work with clinical, commercial, and medical affairs teams to test and deploy technologies, designed to improve tolerability and simplify administration. Whether you're exploring real-world evidence, enhancing trial experience, or planning for market differentiation, we adapt to your goals.

Integrates into clinical protocols

Supports RWE generation

Aligns with strategic portfolio goals

Flexible collaboration, real-world impact.

We work with clinical, commercial, and medical affairs teams to test and deploy technologies, designed to improve tolerability and simplify administration. Whether you're exploring real-world evidence, enhancing trial experience, or planning for market differentiation, we adapt to your goals.

Integrates into clinical protocols

Supports RWE generation

Aligns with strategic portfolio goals

CIPN kicked into a higher gear I left the freeway, I couldn’t feel the brake pedal. That was the last day I was able to drive.

Cancer patient living with drug-induced peripheral neuropathy

CIPN kicked into a higher gear I left the freeway, I couldn’t feel the brake pedal. That was the last day I was able to drive.

Cancer patient living with drug-induced peripheral neuropathy

CIPN kicked into a higher gear I left the freeway, I couldn’t feel the brake pedal. That was the last day I was able to drive.

Cancer patient living with drug-induced peripheral neuropathy

Technologies that
support your team

We’re building a growing set of solutions—each designed to solve a different barrier to delivering better cancer care at scale.

Lotus

Enables safe, at-home cancer treatment — reducing clinic demand and improving patient access.

Lilac

Helps prevent nerve damage that often leads to dose reductions, treatment dropouts, and downstream costs.

Lily

Reduces hair loss, improving patient wellbeing and satisfaction with care.

Technologies that
support your team

We’re building a growing set of solutions—each designed to solve a different barrier to delivering better cancer care at scale.

Lotus

Enables safe, at-home cancer treatment — reducing clinic demand and improving patient access.

Lilac

Helps prevent nerve damage that often leads to dose reductions, treatment dropouts, and downstream costs.

Lily

Reduces hair loss, improving patient wellbeing and satisfaction with care.

Technologies that
support your team

We’re building a growing set of solutions—each designed to solve a different barrier to delivering better cancer care at scale.

Lotus

Enables safe, at-home cancer treatment — reducing clinic demand and improving patient access.

Lilac

Helps prevent nerve damage that often leads to dose reductions, treatment dropouts, and downstream costs.

Lily

Reduces hair loss, improving patient wellbeing and satisfaction with care.

How it fits in

Our technologies are designed for seamless integration—whether as part of clinical trials, combination protocols, or commercial programs. We collaborate with pharmaceutical partners to support co-development, evidence generation, and scalable deployment across treatment settings.

How it fits in

Our technologies are designed for seamless integration—whether as part of clinical trials, combination protocols, or commercial programs. We collaborate with pharmaceutical partners to support co-development, evidence generation, and scalable deployment across treatment settings.

How it fits in

Our technologies are designed for seamless integration—whether as part of clinical trials, combination protocols, or commercial programs. We collaborate with pharmaceutical partners to support co-development, evidence generation, and scalable deployment across treatment settings.

My feet were painful from the cold, with pins and needles, numbness, like a shockwave through my feet. I can't drive or button very well, drop things, and don't hit the right keys on the computer.

Cancer patient describes the dramatic impact of DIPN

My feet were painful from the cold, with pins and needles, numbness, like a shockwave through my feet. I can't drive or button very well, drop things, and don't hit the right keys on the computer.

Cancer patient describes the dramatic impact of DIPN

My feet were painful from the cold, with pins and needles, numbness, like a shockwave through my feet. I can't drive or button very well, drop things, and don't hit the right keys on the computer.

Cancer patient describes the dramatic impact of DIPN

A partner for employee wellbeing and retention

We work with employers and benefits providers to integrate cancer support into your existing plans—through pilots, modelling, and partnerships.

Together, we can reduce absenteeism, improve care satisfaction, and show employees that you’ve got their back when it matters most.

A partner for employee wellbeing and retention

We work with employers and benefits providers to integrate cancer support into your existing plans—through pilots, modelling, and partnerships.

Together, we can reduce absenteeism, improve care satisfaction, and show employees that you’ve got their back when it matters most.

A partner for employee wellbeing and retention

We work with employers and benefits providers to integrate cancer support into your existing plans—through pilots, modelling, and partnerships.

Together, we can reduce absenteeism, improve care satisfaction, and show employees that you’ve got their back when it matters most.

Let’s explore what we can build together

We collaborate with pharmaceutical teams to improve treatment delivery, support tolerability, and unlock new clinical and commercial possibilities.

If you're exploring partnerships, trial integration, or co-development opportunities—we’d love to connect.

Let’s explore what we can build together

We collaborate with pharmaceutical teams to improve treatment delivery, support tolerability, and unlock new clinical and commercial possibilities.

If you're exploring partnerships, trial integration, or co-development opportunities—we’d love to connect.

Let’s explore what we can build together

We collaborate with pharmaceutical teams to improve treatment delivery, support tolerability, and unlock new clinical and commercial possibilities.

If you're exploring partnerships, trial integration, or co-development opportunities—we’d love to connect.

We build technologies that help oncologists make cancer care better for patients.

People want to live, not just survive. We are building technology that aims to enable patients to improve their own experience of healthcare.

Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.

FUNDED BY

On Trial At

Featured In

©2025 Luminate Medical. All Rights Reserved

We build technologies that help oncologists make cancer care better for patients.

People want to live, not just survive. We are building technology that aims to enable patients to improve their own experience of healthcare.

Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.

FUNDED BY

On Trial At

Featured In

©2025 Luminate Medical. All Rights Reserved

We build technologies that help oncologists make cancer care better for patients.

People want to live, not just survive. We are building technology that aims to enable patients to improve their own experience of healthcare.

Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.

FUNDED BY

On Trial At

Featured In

©2025 Luminate Medical. All Rights Reserved